摘要
目的观察脑梗死患者应用疏血通治疗后临床疗效及细胞间粘附分子(ICAM-1)、血管细胞粘附分子(VCAM-1)表达变化。方法采用双盲随机对照方法将60例急性脑梗死患者分为两组,治疗组给予疏血通6ml治疗,对照组常规治疗,疗程为20d。两组于发病1、14、20d静脉血分离血清,采用ELISA测定法测定ICAM-1及VCAM-1的表达。结果疏血通组ICAM-1及VCAM-1明显低于对照组,临床有效率明显高于对照组。结论疏血通能明显降低脑梗死患者细胞间粘附分子(ICAM-1)及血管细胞粘附分子(VCAM-1)水平,同时提高临床疗效。
Objective Aim to find out the effects and mechanisms of shuxuetong in the acute cerebral infarction of patients through the observation of clinical effect and the expressions of proteins ICAM 1 and VCAM 1 Methods Patients were divided randomly into two groups：Control group and shuxuetong group Results Compared with model,shuxuetong were found to increase the clinical effect and decrease the levels of proteins ICAM 1 and VCAM 1 Conclusion Shuxuetong have protection effects on the acute cerebral infarction patients.
出处
《中国实用医药》
2011年第14期116-118,共3页
China Practical Medicine
